AllStar Health Brands Inc (ALST) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAllStar Health Brands Inc (ALST) trades at $0.0004. Allstar Health Brands, Inc. is a specialty healthcare products company offering medicines, natural nutritional supplements, and OTC remedies in the Americas. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for ALST: ALST does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
AllStar Health Brands Inc (ALST) Healthcare & Pipeline Overview
Allstar Health Brands, Inc. is a Canadian-headquartered specialty healthcare products company established in 1997, distributing select medicines, natural nutritional supplements, and over-the-counter remedies across the Americas. The company leverages a Tapout license for globally branded nutraceuticals, including pain relief products, through a marketing partnership with World Wide Entertainment (WWE).
What Is the Investment Thesis for ALST?
Allstar Health Brands, Inc. operates within the health and wellness sector, focusing on the distribution of specialty healthcare products, including natural nutritional supplements and OTC remedies across the Americas. A key value driver for the company is its exclusive Tapout license for globally branded nutraceutical products, such as pain relief sprays and wipes, coupled with a strategic marketing partnership with World Wide Entertainment (WWE). These assets provide a foundation for potential growth by leveraging established brand recognition and broad marketing channels to capitalize on the ongoing consumer interest in health and wellness products. However, the investment profile is significantly influenced by substantial risks. The company trades on the OTC Other tier with an extremely low market capitalization of $0.00B (approximately $5,069) and a share price of $0.00, indicating significant financial risk and potential liquidity challenges. Investors must consider these factors, alongside the company's negative Beta of -0.41, when evaluating its potential.
Based on FMP financials and quantitative analysis
ALST Key Highlights
Market Capitalization: $0.00B, reflecting an extremely low valuation within the broader healthcare sector.
- Beta: -0.41, suggesting a historical tendency for the stock to move inversely to the overall market.
- Dividend Policy: The company does not currently pay a dividend, consistent with its operational stage and capital allocation strategy.
- Operational Scale: Allstar Health Brands, Inc. operates with a lean team of 4 employees, headquartered in Toronto, Canada.
- Market Listing: Trades on the OTC Other tier, characterized by limited public disclosure and potentially lower liquidity compared to major stock exchanges.
Who Are ALST's Competitors?
ALST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ONC BeOne Medicines Ltd. | $358.07 | -0.20% | $38.3B | 96 5-pillar |
| DMRA Galecto, Inc. | $20.65 | +2.08% | $1.27B | 57 5-pillar |
| CGEM Cullinan Therapeutics, Inc. | $15.51 | +6.74% | $953M | 56 5-pillar |
| HITI High Tide Inc. | $2.63 | -1.50% | $231M | 35 5-pillar |
| LFMDP LifeMD, Inc. | $22.74 | -1.75% | $155M | — |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | 32 5-pillar |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | 39 5-pillar |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ALST's Key Strengths?
Exclusive Tapout brand license for globally branded nutraceutical products.
- Strategic marketing and sales partnership with World Wide Entertainment (WWE).
- Established presence in the healthcare sector since its founding in 1997.
- Focus on the growing consumer interest in health and wellness products.
What Are ALST's Weaknesses?
Extremely low market capitalization of $0.00B, indicating significant financial risk.
- Trades on the OTC Other tier with an unknown disclosure status, limiting transparency.
- Market position and key product lines are not clearly defined based on available information.
- Lean operational structure with only 4 employees, potentially limiting scalability and resources.
What Are the Key Risks for ALST?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial risk due to an extremely low market capitalization of $0.00B and a share price of $0.00.
- Lack of transparency and limited disclosure stemming from its OTC Other tier listing and 'Unknown' disclosure status.
- High operational risk given the small employee count of 4, potentially limiting capacity for growth and compliance management.
- Inability to maintain regulatory compliance within the complex and evolving medical and pharmaceutical product industries.
- Challenges in clearly defining and effectively establishing its market position and key product lines amidst intense competition.
What Threats Does ALST Face?
- Intense competition within the highly fragmented health and wellness and nutraceutical markets.
- Regulatory compliance risks inherent in the medical and pharmaceutical product industries.
- Significant liquidity issues and price volatility due to its OTC Other listing and micro-cap status.
- Potential for brand dilution or termination of key partnerships, such as the Tapout license or WWE agreement.
What Are ALST's Competitive Advantages?
- Exclusive Tapout brand license for nutraceutical products, providing a recognized brand for market entry.
- Strategic marketing and sales partnership with World Wide Entertainment (WWE), offering broad promotional reach.
- Established operational history since 1997, indicating longevity in the healthcare sector.
- Focused niche within the health and wellness sector, targeting specific consumer needs with specialty products.
- Geographic focus across the Americas, allowing for targeted market penetration and distribution strategies.
What Does ALST Do?
Allstar Health Brands, Inc., a specialty healthcare products company headquartered in Toronto, Canada, has been operating since its founding in 1997. Initially known as Axxess Pharma, Inc., the company underwent a name change to Allstar Health Brands, Inc. in June 2017, reflecting an evolution in its strategic focus. The company's core mission revolves around enhancing health and quality of life by offering a curated portfolio of select medicines, natural nutritional supplements, and over-the-counter (OTC) remedies. Its operational footprint is primarily concentrated across the Americas, aiming to cater to the diverse health and wellness needs of consumers in these regions. A significant component of Allstar Health Brands' business model is its strategic licensing agreements and partnerships. The company holds the exclusive Tapout license, enabling it to market and sell globally branded nutraceutical products. This portfolio notably includes pain relief sprays and wipes, which are positioned to address consumer demand for accessible and effective self-care solutions. To amplify the reach and market penetration of these Tapout-branded nutraceuticals, Allstar Health Brands, Inc. has forged a partnership with World Wide Entertainment (WWE). This collaboration is designed to leverage WWE's extensive global brand recognition and marketing channels to promote and distribute the Tapout line of products, particularly within the health and wellness segment that aligns with the WWE audience demographic. While the company reportedly focuses on developing and distributing nutritional supplements, the specific market position and the full breadth of its key product lines are not extensively detailed in available information. However, its stated commitment to natural nutritional supplements and OTC remedies positions it within the broader health and wellness sector, a market characterized by growing consumer interest in preventative health and self-medication trends. The company's lean operational structure, with only four employees, suggests a focused approach to its niche market segments within the healthcare industry.
What Products and Services Does ALST Offer?
- Offers a portfolio of specialty healthcare products.
- Distributes select medicines to consumers.
- Provides natural nutritional supplements.
- Sells a range of over-the-counter (OTC) remedies.
- Operates and distributes products across the Americas.
- Holds the exclusive Tapout license for nutraceutical products.
- Markets globally branded nutraceuticals, including pain relief sprays and wipes.
- Partners with World Wide Entertainment (WWE) for marketing and sales of Tapout nutraceuticals.
How Does ALST Make Money?
- Generates revenue through the sale of licensed Tapout-branded nutraceutical products.
- Earns income from the distribution and sale of select medicines.
- Derives revenue from the sale of natural nutritional supplements.
- Sells over-the-counter remedies to consumers in the Americas.
- Leverages strategic partnerships, particularly with WWE, to enhance marketing and sales reach for its products.
What Industry Does ALST Operate In?
Allstar Health Brands, Inc. is positioned within the expansive and dynamic healthcare sector, specifically operating in the Medical - Pharmaceuticals industry with a focus on specialty healthcare products, natural nutritional supplements, and over-the-counter (OTC) remedies. This segment is characterized by a robust and growing consumer interest in health and wellness products, driven by demographic shifts, increased health consciousness, and a preference for preventative care and self-medication. The market for nutraceuticals and OTC remedies is highly competitive, featuring numerous domestic and international players ranging from large pharmaceutical corporations to specialized supplement manufacturers. Allstar Health Brands aims to carve out its niche by leveraging specific product licenses, such as the Tapout brand, and strategic marketing partnerships, like that with WWE. While the company's market position and key product lines are not extensively defined, its operations align with the broader trend of consumers seeking accessible and natural solutions for health maintenance and minor ailments.
Who Are ALST's Key Customers?
- Consumers seeking natural nutritional supplements for general health and wellness.
- Individuals looking for effective over-the-counter remedies for common ailments.
- Customers specifically interested in pain relief products, such as sprays and wipes.
- Consumers located within the geographic regions of the Americas.
- Individuals familiar with or influenced by the Tapout brand or World Wide Entertainment (WWE) promotions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
AllStar Health Brands Inc operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Miami, US. ALST has traded publicly since 2009.
Key Financial Metrics
Return on equity for AllStar Health Brands Inc stands at 7.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
AllStar Health Brands Inc's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ALST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
ALST Latest News
-
ALST Announces Strategic Expansion Across Southern Ontario, Including Land Acquisition for a 5,000-Seat Stadium
Yahoo! Finance: ALST News · Sep 21, 2026
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
ALST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ALST.
Price Targets
Wall Street price target analysis for ALST.
ALST MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ALST; grades run from A+ (80-100) to F (below 30).
Leadership: Peter Daniel Bagi
CEO
Further research would be required to ascertain these aspects of his professional background.
Track Record: Details concerning Peter Daniel Bagi's key achievements, strategic decisions, or significant company milestones directly attributable to his leadership at Allstar Health Brands, Inc. are not explicitly provided in the available source materials. Therefore, a specific track record of his impact on the company's operational or financial performance cannot be detailed within this dossier.
ALST OTC Market Information
Allstar Health Brands, Inc. is listed on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which adhere to stringent listing requirements, financial reporting standards, and corporate governance rules, companies on the OTC Other tier face minimal to no disclosure requirements. This tier is typically reserved for companies that do not meet the standards for higher OTC tiers or major exchanges, often characterized by limited public information, low trading volumes, and heightened investment risk. Investors in OTC Other securities generally have access to significantly less transparent and reliable information compared to exchange-listed companies.
- OTC Tier: OTC Other
- Lack of Transparency: The 'Unknown' disclosure status and OTC Other tier listing mean limited access to reliable and timely financial and operational information, hindering informed decision-making.
- Low Liquidity: Extremely low market capitalization and share price often result in minimal trading volume and wide bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Price Volatility: Stocks on the OTC Other tier can be highly volatile due to low trading volume, limited information, and susceptibility to speculative trading.
- Regulatory Scrutiny: Companies in this tier may face less regulatory oversight, increasing the risk of fraudulent activities or non-compliance with basic business standards.
- Difficulty in Capital Raising: The lack of transparency and low market confidence associated with the OTC Other tier can significantly impede the company's ability to raise capital for growth or operations.
- Verify any available financial statements or disclosures directly from the company's website or regulatory filings, if existent.
- Research the background and track record of management, particularly given the limited public information.
- Assess the legitimacy and enforceability of key licenses and partnerships, such as the Tapout brand and WWE agreement.
- Investigate any past or ongoing regulatory actions, legal issues, or compliance concerns.
- Evaluate the company's business model and product market fit within the competitive health and wellness sector.
- Scrutinize the company's share structure, outstanding shares, and potential for dilution.
- Understand the company's operational capacity and resource allocation, especially with a small employee base.
- Founded in 1997, indicating a relatively long operational history for an OTC-listed company.
- Headquartered in Toronto, Canada, suggesting a formal corporate presence.
- Holds a specific product license (Tapout) for globally branded nutraceutical products.
- Has an established marketing partnership with a recognized entity, World Wide Entertainment (WWE).
- Operates within a legitimate and regulated industry segment (healthcare, nutraceuticals, OTC remedies).
Common Questions About ALST (Healthcare)
What types of products does Allstar Health Brands, Inc. offer under its specialty healthcare focus?
Under its specialty healthcare focus, Allstar Health Brands, Inc. offers a diverse portfolio designed to enhance health and quality of life.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial and operational details available due to OTC Other listing and unknown disclosure status.
- Specific market sizes and growth rates for the company's niche products are not provided in the source data.
- CEO background and track record are not detailed in the provided information.